UroGen Pharma Ltd. (NASDAQ:URGN) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Kathryn Falberg Other companies: Nuvation Bio Inc. (Board of Directors · Since at least Feb 10, 2021); Arcus Biosciences, Inc. (Board Member · Since at least Mar 14, 2018); The Trade Desk, Inc. (Director · Since at least Sep 20, 2016); Tricida Inc (Director · Jun 27, 2018 – Jun 15, 2022 · Past); Sio Gene Therapies Inc (Director · Apr 7, 2017 – May 15, 2017 · Past); BioMarin Pharmaceutical Inc. (Director · Jul 15, 2016 – Jul 15, 2016 · Past); Aimmune Therapeutics Inc (Director · Aug 5, 2015 – Oct 10, 2020 · Past); aTyr Pharma, Inc. (Director · May 6, 2015 – May 24, 2016 · Past); Medivation Inc (Director · Jan 31, 2013 – Sep 28, 2016 · Past); Jazz Pharmaceuticals plc (EVP and CFO · Dec 1, 2009 – Mar 5, 2014 · Past); Novelion Therapeutics Inc (Director · Mar 25, 2009 – May 26, 2011 · Past); Oruka Therapeutics, Inc. (CFO and COO · Feb 23, 2009 – Jun 25, 2009 · Past); Halozyme Therapeutics, Inc. (Director · May 15, 2007 – May 4, 2016 · Past) | Director · Jan 1, 2019 – Jun 7, 2021 · Past |
| Fred E Cohen Other companies: Kyverna Therapeutics, Inc. (Director · Since at least Feb 7, 2024); Intellia Therapeutics, Inc. (Director · Since at least Jan 23, 2019); CareDx, Inc. (Director · Since at least Jul 16, 2014); Progyny, Inc. (Director · Oct 24, 2019 – May 23, 2024 · Past); Roka Bioscience Inc (Director · Jul 16, 2014 – Jun 28, 2017 · Past); Tandem Diabetes Care, Inc. (Director · Nov 13, 2013 – Nov 15, 2018 · Past); Veracyte, Inc. (Director · Oct 29, 2013 – Oct 19, 2020 · Past); Five Prime Therapeutics Inc (Director · Sep 17, 2013 – May 10, 2017 · Past); BioCryst Pharmaceuticals, Inc. (Director · Jul 22, 2013 – Jun 20, 2018 · Past); IQVIA Holdings, Inc. (Director · May 8, 2013 – May 8, 2013 · Past); Genomic Health Inc (Director · May 25, 2006 – Nov 8, 2019 · Past) | Director · Jan 1, 2019 – Aug 6, 2024 · Past |
| Peter P Pfreundschuh Other companies: Y mAbs Therapeutics (EVP, CFO and Treasurer · Since at least Jun 28, 2024); Voyager Therapeutics, Inc. (Chief Financial Officer · Sep 19, 2022 – Feb 21, 2024 · Past); Korro Bio, Inc. (Chief Financial Officer · Dec 1, 2020 – Feb 18, 2022 · Past); Sucampo Pharmaceuticals Inc (CFO · Mar 20, 2017 – Feb 13, 2018 · Past); Immunomedics Inc (Chief Financial Officer · Aug 20, 2015 – Aug 20, 2015 · Past) | Chief Financial Officer · Jan 1, 2019 – Oct 15, 2020 · Past |
| Shawn Tomasello Other companies: Cabaletta Bio, Inc. (Director · Since at least Jul 21, 2023); 4D Molecular Therapeutics, Inc. (Director · Since at least Dec 10, 2020); Kalaris Therapeutics, Inc. (Director · Mar 29, 2022 – Jun 6, 2024 · Past); Gamida Cell Ltd (Director · Jan 1, 2022 – Jan 31, 2024 · Past); Tcr2 Therapeutics Inc (Director · Feb 3, 2021 – Jun 1, 2023 · Past) | Director · Jun 7, 2021 – Jun 7, 2021 · Past |
| Cynthia M. Butitta Other companies: Autolus Therapeutics plc (Chair of the Compensation Committee, Member of the Audit Committee · Since at least Mar 18, 2026); Century Therapeutics, Inc. (Director · Since at least Jun 17, 2021); Olema Pharmaceuticals, Inc. (Director · Since at least Aug 12, 2020); Kite Pharma Inc (Chief Operating Officer · Jun 19, 2014 – Oct 3, 2017 · Past) | of the Audit Committee · Since at least Jan 1, 2019 |
| James A Robinson Jr Other companies: Eledon Pharmaceuticals, Inc. (Director · Since at least Oct 1, 2023); Urovant Sciences Ltd (PEO;CEO/Urovant Sciences, Inc., Director · Mar 1, 2019 – Mar 29, 2021 · Past); Neos Therapeutics Inc (Director · Jan 29, 2019 – Mar 19, 2021 · Past); Alkermes plc (President & COO,Alkermes, Inc. · Mar 5, 2018 – Apr 4, 2019 · Past) | Director · Since at least Jul 25, 2023 |
| Molly Henderson Other companies: Phathom Pharmaceuticals, Inc. (CFO and CBO · Apr 5, 2022 – Apr 7, 2025 · Past); Advaxis Inc (Executive Vice President & CFO · Jun 6, 2018 – May 4, 2020 · Past); Iovance Biotherapeutics, Inc. (CFO · Jun 8, 2015 – Jun 1, 2016 · Past); VirtualScopics Inc (Chief Business/Financial Off. · May 30, 2006 – Jan 29, 2013 · Past) | Chief Financial Officer · Oct 1, 2020 – Jan 31, 2022 · Past |
| Arie Belldegrun Other companies: Allogene Therapeutics, Inc. (Director · Since at least Mar 26, 2021); Kronos Bio Inc (Director · Since at least Oct 8, 2020); Ginkgo Bioworks Holdings, Inc. (Director · Sep 16, 2021 – Jun 12, 2024 · Past) | Director · Since at least Mar 24, 2021 |
| Elizabeth A Barrett Other companies: Sage Therapeutics Inc (Director · Since at least Jun 11, 2025); Allogene Therapeutics, Inc. (Director · Since at least Jul 30, 2021); LifeSci Acquisition II Corp (Director · Nov 20, 2020 – Nov 20, 2020 · Past) | Chief Executive Officer · Since at least Jan 3, 2019 |
| Chris Degnan Other companies: Galera Therapeutics, Inc. (Chief Financial Officer · Nov 6, 2019 – Mar 13, 2023 · Past); Verrica Pharmaceuticals Inc. (Chief Financial Officer · Jun 14, 2018 – Feb 28, 2019 · Past) | Chief Financial Officer · Since at least Oct 8, 2024 |
| Dong Kim Other companies: Canton Strategic Holdings, Inc. (CFO · Mar 27, 2025 – Mar 27, 2025 · Past) | Chief Financial Officer · Mar 25, 2022 – Sep 9, 2024 · Past |
| Leana S. Wen Other companies: Glaukos Corporation (Director · Since at least Mar 1, 2021) | Director · Since at least Sep 8, 2022 |
| Liz Barrett Other companies: Allogene Therapeutics, Inc. (President and Chief Executive Officer of UroGen, Former CEO of Novartis Oncology · Since at least Nov 6, 2026) | President and Chief Executive Officer · Since at least Nov 4, 2026 |
| Alison Hardgrove | SVP, Human Resources · Since at least Nov 5, 2026 |
| Chris Degnan | Chief Financial Officer · Since at least Mar 2, 2026 |
| Cindy Romano | Director, Corporate Communications · Since at least Nov 3, 2026 |
| Daniel Wildman | of the Compensation Committee; of the Compliance Committee · Since at least Nov 5, 2026 |
| Jason Smith | General Counsel and Chief Compliance Officer · Since at least Aug 31, 2020 |
| Jim Ottinger | EVP, Regulatory Affairs and Quality · Since at least Nov 4, 2026 |
| Jim Robinson | Director · Since at least Aug 28, 2026 |
| Marina Konorty | EVP, Research & Development and Technical Operations · Since at least Nov 5, 2026 |
| Mark P. Schoenberg | Chief Medical Officer · Since at least Jan 1, 2019 |
| Michael J. Louie | Chief Development Officer · Since at least Jul 7, 2025 |
| Stephen Mullennix | Chief Operating Officer · Jan 1, 2019 – Apr 26, 2020 · Past |
| Stuart Holden | of the Audit Committee; of the Compliance Committee · Since at least Jan 1, 2019 |
| Timothy Simon | SVP, Business Development and Portfolio Strategy · Since at least Nov 5, 2026 |
| Vincent Perrone | Senior Director, Investor Relations · Since at least Nov 3, 2026 |